Story perspectives

Genetic Variations May Personalize IBS Treatment Response

3/24/2026

Summary

Story summary

Genetic variation in drug metabolism may affect how irritable bowel syndrome treatments work.
Specific genetic markers such as SLC6A4 may predict treatment responses, but these findings remain exploratory and are not integrated into routine care.
Advances in pharmacogenomics aim to personalize IBS treatment by combining genetic, microbiome, and environmental data.
Significant regulatory and economic challenges hinder the widespread adoption of precision medicine in clinical practice.

1 of 1

Story summary

Genetic variation in drug metabolism may affect how irritable bowel syndrome treatments work.
Specific genetic markers such as SLC6A4 may predict treatment responses, but these findings remain exploratory and are not integrated into routine care.
Advances in pharmacogenomics aim to personalize IBS treatment by combining genetic, microbiome, and environmental data.
Significant regulatory and economic challenges hinder the widespread adoption of precision medicine in clinical practice.